Side-by-side comparison of AI visibility scores, market position, and capabilities
German consumer goods and industrial adhesive company with €21B revenue; Loctite adhesives and Schwarzkopf hair care competing with 3M and P&G through EV battery adhesive growth.
Henkel is a German multinational consumer goods and industrial company producing branded consumer goods (Schwarzkopf hair care, Persil laundry detergent, Dial soap, Right Guard deodorant) alongside adhesive technologies for industrial, automotive, and electronics applications. Listed on the Frankfurt Stock Exchange (XETRA: HENKY) and headquartered in Düsseldorf, Germany, Henkel generates approximately €21 billion in annual revenue through two main divisions: Adhesive Technologies (industrial and consumer adhesives, sealants, surface treatments) and Consumer Brands (hair colorants, styling products, laundry/home care).\n\nHenkel's Adhesive Technologies segment produces Loctite adhesives (a globally recognized industrial adhesive brand), BONDERITE surface treatments for automotive and aerospace metal processing, and consumer adhesives (Pritt glue sticks). This segment serves automotive manufacturers (adhesives used in EV battery assembly are a growing opportunity), electronics manufacturers, and aerospace and defense. The Consumer Brands segment includes Schwarzkopf (professional hair care sold in salons and retail), Syoss hair care, Persil laundry detergent, and Fa body care.\n\nIn 2025, Henkel is executing a strategic reorganization that merged its former Laundry & Home Care and Beauty Care divisions into a single Consumer Brands segment to improve efficiency. The Adhesive Technologies segment benefits from EV battery manufacturing growth (structural adhesives for battery packs and EV body construction are growing categories). Henkel competes with 3M, Illinois Tool Works, and Bostik for industrial adhesives, and with Procter & Gamble, Unilever, and Revlon for consumer goods. The 2025 strategy emphasizes driving Adhesive Technologies growth through EV and semiconductor manufacturing adhesive applications.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.